抗癌药物舒洛地尔在大鼠、猴子和人体内代谢过程中茚磺酰脲的形成。 - Suppr | 超能文献

Formation of indenesulfonylureas in the metabolism of the anticancer agent sulofenur in rats, monkeys, and humans.

作者信息

Ehlhardt W J, Zimmermann J L, Ray J E, Toth J E

机构信息

Department of Drug Metabolism, Lilly Research Laboratories, Indianapolis, IN 46285.

出版信息

Drug Metab Dispos. 1992 Nov-Dec;20(6):958-61.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Formation of indenesulfonylureas in the metabolism of the anticancer agent sulofenur in rats, monkeys, and humans.抗癌药物舒洛地尔在大鼠、猴子和人体内代谢过程中茚磺酰脲的形成。

Drug Metab Dispos. 1992 Nov-Dec;20(6):958-61.

2

Metabolism and disposition of the anticancer agent sulofenur in mouse, rat, monkey, and human.抗癌药物舒洛地尔在小鼠、大鼠、猴和人体内的代谢与处置。

Drug Metab Dispos. 1991 Mar-Apr;19(2):370-5.

3

Disposition and metabolism of the sulfonylurea oncolytic agent LY295501 in mouse, rat, and monkey.磺酰脲类溶瘤药物LY295501在小鼠、大鼠和猴体内的处置与代谢

Drug Metab Dispos. 1997 Jun;25(6):701-8.

4

Pharmacokinetics of the anticancer agent sulofenur in mice, rats, monkeys, and dogs.抗癌药物舒洛地尔在小鼠、大鼠、猴子和狗体内的药代动力学。

J Pharm Sci. 1993 Jul;82(7):683-8. doi: 10.1002/jps.2600820703.

5

Glutathione and mercapturic acid conjugates of sulofenur and their activity against a human colon cancer cell line.舒洛地尔的谷胱甘肽和硫醚氨酸共轭物及其对人结肠癌细胞系的活性。

Drug Metab Dispos. 2002 Mar;30(3):331-5. doi: 10.1124/dmd.30.3.331.

6

Comparison of metabolism and toxicity to the structure of the anticancer agent sulofenur and related sulfonylureas.

Chem Res Toxicol. 1992 Sep-Oct;5(5):667-73. doi: 10.1021/tx00029a012.

7

Glutathione-dependent metabolism of the antitumor agent sulofenur. Evidence for the formation of p-chlorophenyl isocyanate as a reactive intermediate.抗肿瘤药物舒洛地芬的谷胱甘肽依赖性代谢。对作为反应性中间体的对氯苯基异氰酸酯形成的证据。

Chem Res Toxicol. 2002 Feb;15(2):240-8. doi: 10.1021/tx0155698.

8

[Flavone acetic acid and LY 186641 interfere in various ways in Jaffé's reaction].[黄酮醋酸和LY 186641以多种方式干扰贾菲反应]

Bull Cancer. 1989;76(8):839-41.

9

Pharmacokinetics of a novel butylated hydroxytoluene-thiazolidinone CNS antiischemic agent LY256548 in rats, mice, dogs, and monkeys.新型丁基化羟基甲苯-噻唑烷二酮类中枢神经系统抗缺血药物LY256548在大鼠、小鼠、犬和猴体内的药代动力学

Drug Metab Dispos. 1990 Sep-Oct;18(5):674-9.

10

Metabolism of the antiarrhythmic agent, indecainide, in rats, dogs, and monkeys.抗心律失常药物茚地卡尼在大鼠、狗和猴体内的代谢。

Drug Metab Dispos. 1984 Nov-Dec;12(6):691-7.

引用本文的文献

1

Antitumor diarylsulfonylureas: novel agents with unfulfilled promise.

Invest New Drugs. 1996;14(3):271-80. doi: 10.1007/BF00194530.